+Compare
PRGO
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
4.13B

PRGO Perrigo Company PLC Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for PRGO with price predictions
07:00 PM EST Dec 04, 2023

PRGO's RSI Indicator climbs out of oversold territory

The RSI Indicator for PRGO moved out of oversold territory on October 31, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In of the 41 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 10, 2023. You may want to consider a long position or call options on PRGO as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PRGO just turned positive on November 03, 2023. Looking at past instances where PRGO's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

PRGO moved above its 50-day moving average on November 22, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PRGO crossed bullishly above the 50-day moving average on November 28, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRGO advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 197 cases where PRGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PRGO broke above its upper Bollinger Band on November 15, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.871) is normal, around the industry mean (47.989). PRGO has a moderately high P/E Ratio (380.750) as compared to the industry average of (60.542). Projected Growth (PEG Ratio) (0.735) is also within normal values, averaging (2.883). Dividend Yield (0.036) settles around the average of (0.027) among similar stocks. P/S Ratio (0.891) is also within normal values, averaging (65.502).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PRGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.76B. The market cap for tickers in the group ranges from 246 to 82.08B. ZTS holds the highest valuation in this group at 82.08B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 29%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was -4%. INNPF experienced the highest price growth at 6,367%, while CNTRF experienced the biggest fall at -65%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 46% and the average quarterly volume growth was 64%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 68
Price Growth Rating: 53
SMR Rating: 84
Profit Risk Rating: 91
Seasonality Score: 25 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

PRGO is expected to report earnings to rise 28.91% to 82 cents per share on February 29

Perrigo Company PLC PRGO Stock Earnings Reports
Q4'23
Est.
$0.82
Q3'23
Beat
by $0.03
Q2'23
Beat
by $0.12
Q1'23
Missed
by $0.01
Q4'22
Beat
by $0.05
The last earnings report on November 07 showed earnings per share of 63 cents, beating the estimate of 61 cents. With 1.09M shares outstanding, the current market capitalization sits at 4.13B.
A.I.Advisor
published Dividends

PRGO is expected to pay dividends on December 19, 2023

Perrigo Company PLC PRGO Stock Dividends
A dividend of $0.27 per share will be paid with a record date of December 19, 2023, and an ex-dividend date of November 30, 2023. The last dividend of $0.27 was paid on September 19. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
The Sharp Building
Phone
+353 17094000
Employees
8900
Web
https://www.perrigo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TPMN25.44-0.03
-0.11%
Timothy Plan Market Neutral ETF
HQL12.22-0.02
-0.16%
abrdn Life Sciences Investors
NFRA51.87-0.15
-0.29%
FlexShares STOXX Global Broad Infras ETF
YUMY15.82-0.12
-0.73%
VanEck Future of Food ETF
ENFR23.03-0.30
-1.29%
Alerian Energy Infrastructure ETF

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with VTRS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-1.43%
VTRS - PRGO
48%
Loosely correlated
-0.62%
PAHC - PRGO
36%
Loosely correlated
+1.87%
ELAN - PRGO
33%
Loosely correlated
+0.23%
ZTS - PRGO
32%
Poorly correlated
-1.36%
SUPN - PRGO
29%
Poorly correlated
-1.17%
More

Groups containing PRGO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-1.43%
pharmaceuticals
(undefined stocks)
40%
Loosely correlated
-0.48%
drugs
(undefined stocks)
39%
Loosely correlated
-0.95%
europe
(undefined stocks)
30%
Poorly correlated
-0.54%
generic drugs
(undefined stocks)
30%
Poorly correlated
-1.51%
Pharmaceuticals
(undefined stocks)
5%
Poorly correlated
+0.01%
More